Selected research
Industry Research
Cannabinoid Profiling Industry Research Report 2026
Market perspective
The global Cannabinoid Profiling market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cannabinoid Profiling market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cannabinoid Profiling market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cannabinoid Profiling market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cannabinoid Profiling include Saskatchewan Research Council (SRC), SC Labs, Steep Hill, SGS Canada, CW ANALYTICAL, PharmLabs, GreenLeaf Lab, Kaycha Holdings and American Clinical Solutions, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cannabinoid Profiling market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cannabinoid Profiling.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cannabinoid Profiling Market by Company
Saskatchewan Research Council (SRC)
SC Labs
Steep Hill
SGS Canada
CW ANALYTICAL
PharmLabs
GreenLeaf Lab
Kaycha Holdings
American Clinical Solutions
CannaSafe
Aurum Labs
A&L Canada Laboratories
Royalmount Laboratories
Confidence Analytics
ACT Laboratories
Cannabinoid Profiling Segment by Type
Gas Chromatography
Liquid Chromatography
Cannabinoid Profiling Segment by Application
Cannabis Drug Manufacturers
Cannabis Cultivators/Growers
Research Institutes
Others
Cannabinoid Profiling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabinoid Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cannabinoid Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabinoid Profiling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cannabinoid Profiling companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gas Chromatography
- Liquid Chromatography
Applications
- Cannabis Drug Manufacturers
- Cannabis Cultivators/Growers
- Research Institutes
- Others
Companies covered
- Saskatchewan Research Council (SRC)
- SC Labs
- Steep Hill
- SGS Canada
- CW ANALYTICAL
- PharmLabs
- GreenLeaf Lab
- Kaycha Holdings
- American Clinical Solutions
- CannaSafe
- Aurum Labs
- A&L Canada Laboratories
- Royalmount Laboratories
- Confidence Analytics
- ACT Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cannabinoid Profiling by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gas Chromatography
- 2.2.3 Liquid Chromatography
- 2.3 Cannabinoid Profiling by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cannabis Drug Manufacturers
- 2.3.3 Cannabis Cultivators/Growers
- 2.3.4 Research Institutes
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Cannabinoid Profiling Breakdown Data by Type
- 3.1 Global Cannabinoid Profiling Historic Market Size by Type (2021-2026)
- 3.2 Global Cannabinoid Profiling Forecasted Market Size by Type (2027-2032)
4 Cannabinoid Profiling Breakdown Data by Application
- 4.1 Global Cannabinoid Profiling Historic Market Size by Application (2021-2026)
- 4.2 Global Cannabinoid Profiling Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cannabinoid Profiling Market Perspective (2021-2032)
- 5.2 Global Cannabinoid Profiling Growth Trends by Region
- 5.2.1 Global Cannabinoid Profiling Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cannabinoid Profiling Historic Market Size by Region (2021-2026)
- 5.2.3 Cannabinoid Profiling Forecasted Market Size by Region (2027-2032)
- 5.3 Cannabinoid Profiling Market Dynamics
- 5.3.1 Cannabinoid Profiling Industry Trends
- 5.3.2 Cannabinoid Profiling Market Drivers
- 5.3.3 Cannabinoid Profiling Market Challenges
- 5.3.4 Cannabinoid Profiling Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cannabinoid Profiling Players by Revenue
- 6.1.1 Global Top Cannabinoid Profiling Players by Revenue (2021-2026)
- 6.1.2 Global Cannabinoid Profiling Revenue Market Share by Players (2021-2026)
- 6.2 Global Cannabinoid Profiling Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cannabinoid Profiling Head Office and Area Served
- 6.4 Global Cannabinoid Profiling Players, Product Type & Application
- 6.5 Global Cannabinoid Profiling Manufacturers Established Date
- 6.6 Global Cannabinoid Profiling Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cannabinoid Profiling Market Size (2021-2032)
- 7.2 North America Cannabinoid Profiling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cannabinoid Profiling Market Size by Country (2021-2026)
- 7.4 North America Cannabinoid Profiling Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cannabinoid Profiling Market Size (2021-2032)
- 8.2 Europe Cannabinoid Profiling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cannabinoid Profiling Market Size by Country (2021-2026)
- 8.4 Europe Cannabinoid Profiling Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cannabinoid Profiling Market Size (2021-2032)
- 9.2 Asia-Pacific Cannabinoid Profiling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cannabinoid Profiling Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cannabinoid Profiling Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cannabinoid Profiling Market Size (2021-2032)
- 10.2 South America Cannabinoid Profiling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cannabinoid Profiling Market Size by Country (2021-2026)
- 10.4 South America Cannabinoid Profiling Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cannabinoid Profiling Market Size (2021-2032)
- 11.2 Middle East & Africa Cannabinoid Profiling Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cannabinoid Profiling Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cannabinoid Profiling Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Saskatchewan Research Council (SRC)
- 12.1.1 Saskatchewan Research Council (SRC) Company Information
- 12.1.2 Saskatchewan Research Council (SRC) Business Overview
- 12.1.3 Saskatchewan Research Council (SRC) Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.1.4 Saskatchewan Research Council (SRC) Cannabinoid Profiling Product Portfolio
- 12.1.5 Saskatchewan Research Council (SRC) Recent Developments
- 12.2 SC Labs
- 12.2.1 SC Labs Company Information
- 12.2.2 SC Labs Business Overview
- 12.2.3 SC Labs Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.2.4 SC Labs Cannabinoid Profiling Product Portfolio
- 12.2.5 SC Labs Recent Developments
- 12.3 Steep Hill
- 12.3.1 Steep Hill Company Information
- 12.3.2 Steep Hill Business Overview
- 12.3.3 Steep Hill Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.3.4 Steep Hill Cannabinoid Profiling Product Portfolio
- 12.3.5 Steep Hill Recent Developments
- 12.4 SGS Canada
- 12.4.1 SGS Canada Company Information
- 12.4.2 SGS Canada Business Overview
- 12.4.3 SGS Canada Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.4.4 SGS Canada Cannabinoid Profiling Product Portfolio
- 12.4.5 SGS Canada Recent Developments
- 12.5 CW ANALYTICAL
- 12.5.1 CW ANALYTICAL Company Information
- 12.5.2 CW ANALYTICAL Business Overview
- 12.5.3 CW ANALYTICAL Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.5.4 CW ANALYTICAL Cannabinoid Profiling Product Portfolio
- 12.5.5 CW ANALYTICAL Recent Developments
- 12.6 PharmLabs
- 12.6.1 PharmLabs Company Information
- 12.6.2 PharmLabs Business Overview
- 12.6.3 PharmLabs Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.6.4 PharmLabs Cannabinoid Profiling Product Portfolio
- 12.6.5 PharmLabs Recent Developments
- 12.7 GreenLeaf Lab
- 12.7.1 GreenLeaf Lab Company Information
- 12.7.2 GreenLeaf Lab Business Overview
- 12.7.3 GreenLeaf Lab Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.7.4 GreenLeaf Lab Cannabinoid Profiling Product Portfolio
- 12.7.5 GreenLeaf Lab Recent Developments
- 12.8 Kaycha Holdings
- 12.8.1 Kaycha Holdings Company Information
- 12.8.2 Kaycha Holdings Business Overview
- 12.8.3 Kaycha Holdings Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.8.4 Kaycha Holdings Cannabinoid Profiling Product Portfolio
- 12.8.5 Kaycha Holdings Recent Developments
- 12.9 American Clinical Solutions
- 12.9.1 American Clinical Solutions Company Information
- 12.9.2 American Clinical Solutions Business Overview
- 12.9.3 American Clinical Solutions Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.9.4 American Clinical Solutions Cannabinoid Profiling Product Portfolio
- 12.9.5 American Clinical Solutions Recent Developments
- 12.10 CannaSafe
- 12.10.1 CannaSafe Company Information
- 12.10.2 CannaSafe Business Overview
- 12.10.3 CannaSafe Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.10.4 CannaSafe Cannabinoid Profiling Product Portfolio
- 12.10.5 CannaSafe Recent Developments
- 12.11 Aurum Labs
- 12.11.1 Aurum Labs Company Information
- 12.11.2 Aurum Labs Business Overview
- 12.11.3 Aurum Labs Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.11.4 Aurum Labs Cannabinoid Profiling Product Portfolio
- 12.11.5 Aurum Labs Recent Developments
- 12.12 A&L Canada Laboratories
- 12.12.1 A&L Canada Laboratories Company Information
- 12.12.2 A&L Canada Laboratories Business Overview
- 12.12.3 A&L Canada Laboratories Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.12.4 A&L Canada Laboratories Cannabinoid Profiling Product Portfolio
- 12.12.5 A&L Canada Laboratories Recent Developments
- 12.13 Royalmount Laboratories
- 12.13.1 Royalmount Laboratories Company Information
- 12.13.2 Royalmount Laboratories Business Overview
- 12.13.3 Royalmount Laboratories Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.13.4 Royalmount Laboratories Cannabinoid Profiling Product Portfolio
- 12.13.5 Royalmount Laboratories Recent Developments
- 12.14 Confidence Analytics
- 12.14.1 Confidence Analytics Company Information
- 12.14.2 Confidence Analytics Business Overview
- 12.14.3 Confidence Analytics Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.14.4 Confidence Analytics Cannabinoid Profiling Product Portfolio
- 12.14.5 Confidence Analytics Recent Developments
- 12.15 ACT Laboratories
- 12.15.1 ACT Laboratories Company Information
- 12.15.2 ACT Laboratories Business Overview
- 12.15.3 ACT Laboratories Revenue in Cannabinoid Profiling Business (2021-2026)
- 12.15.4 ACT Laboratories Cannabinoid Profiling Product Portfolio
- 12.15.5 ACT Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst